cyclic citrullinated peptide
Recently Published Documents


TOTAL DOCUMENTS

524
(FIVE YEARS 77)

H-INDEX

47
(FIVE YEARS 3)

2022 ◽  
Vol 12 (2) ◽  
pp. 109-114
Author(s):  
Devolina Bhowmik ◽  
Manash Chandra Sarker ◽  
Shirin Tarafder ◽  
Hosne Jahan ◽  
Mst Naznin Tarana ◽  
...  

Introduction: Psoriatic arthritis (PsA) is established as a multifactorial disease resulting from a complex interplay between genetic, environmental and immunological factors. It is a seronegative arthritis but rheumatoid factor may be present in up to 15% of PsA patients Antibodies recognizing a cyclic citrullinated peptide are highly speciûc for rheumatoid arthritis (RA) but their role in PsA remains unclear. An increased prevalence of anti-CCP antibody in PsA is also reported. Study shows that HLA-DRB1 shared epitope is signiûcantly associated with the presence of anti-CCP antibody in PsA patients but this type of association is not found with other human leukocyte antigens. Objectives: The aim of this study was to investigate the frequency of anti-CCP and RF in PsA patients and their associations with HLA-B locus antigens. Methods: In this cross sectional study, we selected 50 unrelated consecutive patients with PsA according to CASPAR criteria for PsA. 6 ml of blood was collected from each patient for HLAB locus typing, RA test and test for anti-CCP. Patient’s serum samples were tested for RF by Nephelometric system and tests for anti-CCP were done by ELISA. HLA-B locus typing was done by PCR with sequence specific primer. Results: Among 50 PsA patients, 27 (54%) are female and 23 (46%) are male. RA test is positive in 10 (20%) patients and anti-CCP is positive in 7 (14%) patients. Significant association was found between HLA-B*37 and RF (p value= < 0.001). Conclusion: RF is present in 10 (20%) and anti-CCP is present in 7 (14%) PsA patients. HLAB* 37 was significantly found in RF positive patients. J Shaheed Suhrawardy Med Coll 2020; 12(2): 109-114


2021 ◽  
Vol 7 (12) ◽  
pp. 116-121
Author(s):  
Ch. Eshbaeva ◽  
A. Mamasaidov ◽  
K. Sakibaev ◽  
Zh. Imetova ◽  
Zh. Abdullaeva

Research relevance: prognosis of early rheumatoid arthritis (RA) course remains an unresolved problem, which dictates the need to identify new factors affecting the activity and course of the disease. Research objectives: it is assumed that the cause of immunopathological reactions in early RA is a dysregulation of the immune response resulting from an imbalance in the function of T- and B-lymphocytes, namely, the immunodeficiency of the T-lymphocyte system, which leads to uncontrolled synthesis of immunoglobulins by B-lymphocytes, in particular, organo- and tissue-specific antibodies. Research methods: this article analyzes occurrence frequency, pathogenetic and clinical significance of antibodies to cyclic citrullinated peptide (ACCP) in early rheumatoid arthritis (RA). Research results: in this work, in patients with early RA, the detection rate of ACCP was 68.8%, the frequency of detection of ACCP was higher than that of rheumatoid factor. Conclusions: in the examined patients with early RA, the presence of ACCP did not depend on gender and age but depended on the duration of the disease.


2021 ◽  
Vol 49 (9) ◽  
pp. 030006052110477
Author(s):  
Xiaochun Yang ◽  
Yue Cai ◽  
Bin Xue ◽  
Bo Zhang

Objective This meta-analysis explored the diagnostic value of anti-cyclic citrullinated peptide antibody (anti-CCP) and rheumatoid factor (RF) for rheumatoid arthritis (RA) in the Asian population. Methods Embase, Medline, Cochrane Library, Chinese Science and Technology Periodicals, China National Knowledge Infrastructure, and China Wanfang Databases were searched from 1 January 2000 to 1 February 2021 to collect studies on the combined detection of anti-CCP and RF for diagnosing RA. The sensitivity, specificity, diagnostic odds ratio (DOR), positive likelihood ratio (+LR), and negative likelihood ratio (−LR) were combined and analyzed. Summary receiver operating characteristic (SROC) curves were drawn. Results Twenty-four published papers were analyzed, including 21 combined in series and 8 combined in parallel. In the tandem analysis, the sensitivity = 0.64 [95% confidence interval (CI): 0.58–0.70], specificity = 0.97 (95%CI: 0.95–0.98), +LR = 19.70 (95%CI: 12.74–30.46), −LR = 0.37 (95%CI: 0.31–0.43), DOR = 53.43 (95%CI: 34.46–82.40), and area under the SROC curve = 0.89. In the parallel combination, the sensitivity = 0.87 (95%CI: 0.80–0.92), specificity = 0.76 (95%CI: 0.67–0.84), +LR = 3.68 (95%CI: 2.62–5.17), −LR = 0.17 (95%CI: 0.11–0.26), DOR = 21.56 (95%CI: 11.63–39.99), and area under the SROC curve = 0.89. Conclusion Anti-CCP and RF combined detection improves the diagnostic efficiency of RA, providing a potential strategy for early clinical screening in the Asian population. This trial was retrospectively registered in the INPLASY/Research Registry ( https: //inplasy.com/ ) with the registration number INPLASY202180106.


2021 ◽  
Vol 12 ◽  
Author(s):  
Xuan Tang ◽  
Zehao Liu ◽  
Zhihua Yang ◽  
Shengmei Xu ◽  
Maojie Wang ◽  
...  

Objectives: To evaluate the current evidence whether Chinese medicine compound (CMC) can reduce the serum levels of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (anti-CCP).Methods: We comprehensively searched PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure (CNKI), the Database for Chinese Technical Periodicals (VIP), and Wanfang data. We then performed a systematic review and meta-analysis of all randomized controlled trials (RCTs) assessing the CMC therapy methods. This study is registered with PROSPERO, number CRD42020216284.Results: In total, 65 studies were eligible for inclusion, including 6099 patients. The result of the meta-analysis showed that compared with common Western medicine therapy, CMC monotherapy or combined with Western medicine was able to reduce serum RF (SMD= −0.85, 95%CI −1.04 to −0.67) and anti-CCP (SMD= −0.56, 95%CI −0.79 to −0.32) levels to some extent. In the efficacy meta-analysis, a greater number of CMC-treated patients achieved the efficacy criteria after a period of treatment, where the relative risk (RR) was 1.20 [1.08, 1.33] for achieving ACR20, 1.57 [1.38, 1.78] for ACR50, and 2.21 [1.72, 2.84] for ACR70. At the same time, there was a statistically significant difference in the effective rate of the patient's TCM symptoms (RR = 1.22, 95%CI 1.19–1.26).Conclusions: Through this meta-analysis and systematic review, we found that CMC for the treatment of RA is effective in reducing RF and anti-CCP levels and might have better clinical efficacy than Western medicine monotherapy. Some active components are responsible for this efficacy and worth further exploring.


2021 ◽  
Vol 7 (6) ◽  
Author(s):  
A. Chaldanbaeva ◽  
A. Chargynova

The article presents the results of studies of immunological and biochemical characteristics of diseases of the osteoarticular system among residents of Bishkek. The studies were carried out on residents of Bishkek, men and women aged 21–74, in the spring of 2019, in the fall of 2019 and in the fall of 2020. A total of 1358 people were examined for ACCP, of which 282 residents of Bishkek were found to have an ACCP content higher than the norm, among which 238 were women and 44 were men. The level of antibodies to cyclic citrullinated peptide (ACCP) was determined in blood serum by immunochemiluminescence analysis. Biochemical studies aimed at identifying the activity of the process and immune inflammation consisted of determining the levels of rheumatoid factor (RF), C-reactive protein (CRP), Antistreptolysin-O (ASL-O) and uric acid (MC) according to generally accepted methods. Out of the selected 282 Bishkek residents, 17 men and 82 women belong to the confirmation group, while 27 men and 156 women are in the group of people with increased levels of ACCP were first established. ACCPs mainly belong to the IgG class and are found in the blood at the earliest stages of rheumatoid arthritis disease (1–2 years before the onset of the first symptoms) and their specificity in rheumatoid arthritis is about 97%. They are detected at very early stages of the disease, which explains the distribution of the surveyed residents of Bishkek by groups. Analysis by sex distribution showed that in all groups women prevail than men, since it is known from scientific literature source that diseases of the osteoarticular system, in particular rheumatoid arthritis, are more susceptible to women than men. Women get sick more often than men 2–5 times more, which was found in our studies, the ratio of men and women is on average 1:3.4–5.6. It has been proven that damage to the osteoarticular system can occur at any age. According to our data, 47.7% of the total number of surveyed men were aged 35–60 years, 45.5% were men aged 61–74 years. At the same time, among women, 37% were aged 35–60 years, 36.3% were women aged 61–74 years. According to scientific literature sources, the incidence of rheumatoid arthritis increases with age, over 60 years old reaches its maximum value (more than 2%), the population is aging when RA grows. Gender differences are also lost, the ratio of women to men is 2:1 or less. At the same time, rheumatoid arthritis can develop at any age, most often from 35 to 50 years, but it can also be in childhood and in the elderly. According to our results, among women under 35 years of age in the confirmation group, the prevalence of RA was 28.3%, at the age of 36-60 years 58.8%, and at the age of over 61 years — 43.6%. And in the group of primary confirmation, women under 35 years old accounted for 16.7%, at the age of 36-60 they make up 20.4% and over 60 years old — 28.5%. As you know, ACCP can be detected in 30% of cases of seronegative rheumatoid arthritis (negative for rheumatoid factor), which is advisable in the diagnosis of early seronegative RA, in differential diagnosis with other rheumatic diseases. Elevated ACCP levels in healthy individuals indicate a significant increase in the risk of developing RA. Rheumatoid factor is an autoimmune antibody, an immunoglobulin protein (IgM) produced by the body's immune system. Autoantibodies attack their own tissues, mistaking them for foreign ones. Although the nature of rheumatoid factor is still poorly understood, its presence is an indicator of inflammatory and autoimmune processes. With rheumatoid arthritis symptoms, high rheumatoid factor levels are likely to indicate seropositive rheumatoid arthritis. However, even a negative test result does not exclude that the patient has these diseases. Antibodies to cyclic citrullinated peptide and RF are currently recognized as an informative serological marker of rheumatoid arthritis. Based on studies carried out at different times of the year (spring, autumn 2019, autumn 2020), it was found that the season does not have a significant effect on the content of the ACCP level, although residents of Bishkek (men and women) often complain of pain in the joints in the fall. than in the spring. This is confirmed by the highest content of ACCP among women, as well as men over 35 years old to 74 years old.


Sign in / Sign up

Export Citation Format

Share Document